CHRISTOPHER FRICK: Open Payments
NPI 1700010014 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 39 payments from 16 companies in 2025. Trend: 2023 $21,016 · 2024 $7,230 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 5 | $185 |
| Novartis Pharmaceuticals Corporation | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| Amgen Inc. | 4 | $63 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $62 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| HEARTFLOW, INC. | 1 | $29 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
Products named: LEQVIO, Kerendia, REPATHA, WAINUA, LifeVest, FFRct, ELIQUIS, Wegovy.
Industry payments across OH — which companies pay providers there.
